Font: Financial Modeling Prep • May 29, 2026
An analyst at Truist Financial shows confidence in Costco Wholesale Corporation (NASDAQ: COST), raising its price target to $1,011 from $977. This new target suggests a potential 6.8% upside from its price at the time. Costco is a leading wholesale retailer that offers goods to members at low prices.
This optimism is supported by the company's recent financial performance. In its third quarter, Costco reported strong revenue of $70.5 billion, which was better than expected. The company’s adjusted comparable sales, which compare sales at stores open for at least a year, increased by 6.6%.
Digital sales are also a major driver of growth for Costco. Digitally-enabled comparable sales surged by 20.8%, fueled by a 37% increase in website and app traffic. This success comes from new features like better personalization and same-day delivery options, enhancing the overall customer experience.
To support this growth, Costco is investing heavily in its future. As highlighted by Gurufocus, the company plans to spend approximately $6.5 billion on capital expenditures in fiscal 2026. This significant investment will help open more than 30 new warehouses each year, driving further market expansion.
Despite a minor miss on earnings per share (EPS), the company still grew its EPS by 15.2%. However, investors note its high forward price-to-earnings (P/E) ratio of 53x. This valuation ratio suggests the stock's price is high compared to its earnings, reflecting high expectations for future growth and market confidence.
|
DCX§>
Digital Currency X Technology Inc.
|
$0.06
-17.85%
|
|
RETO§>
ReTo Eco-Solutions, Inc.
|
$0.17
4.67%
|
|
ATCH§>
AtlasClear Holdings, Inc.
|
$0.19
-0.81%
|
|
GLND§>
Greenland Energy Company Common Stock
|
$5.35
83.85%
|
|
ATYR§>
aTyr Pharma, Inc.
|
$0.34
-10.02%
|
|
INTC§>
Intel Corp.
|
$127.39
3.91%
|
|
ONDS§>
Ondas Holdings Inc.
|
$7.60
2.70%
|
|
CTNT§>
Cheetah Net Supply Chain Service Inc.
|
$0.03
-16.41%
|
|
TWG§>
Top Wealth Group Holding Limited Ordinary Shares
|
$0.21
-23.96%
|
|
APUS§>
Apimeds Pharmaceuticals US, Inc
|
$4.92
114.85%
|